Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Author(s) -
Yuichiro� Doki,
Jaffer A. Ajani,
Ken Kato,
Jianming Xu,
Lucjan Wyrwicz,
Satoru Motoyama,
Takashi Ogata,
Hisato Kawakami,
ChihHung Hsu,
Antoine Adenis,
Farid El Hajbi,
Maria Di Bartolomeo,
Maria Ignez Braghiroli,
Eva Holtved,
Sandra A. Ostoich,
Hye R. Kim,
Masaki Ueno,
Wasat Mansoor,
WenChi Yang,
Tianshu Liu,
John Bridgewater,
Tomoki Makino,
Ioannis Xynos,
Xuan Liu,
Ming Lei,
Kaoru Kondo,
Apurva Patel,
Joseph Gricar,
Ian Chau,
Yuko Kitagawa
Publication year - 2022
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa2111380
Subject(s) - nivolumab , medicine , hazard ratio , chemotherapy , oncology , population , ipilimumab , gastroenterology , confidence interval , cancer , immunotherapy , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom